What Trump’s Executive Order means for cannabis research Jan 30 2026 On December 18, 2025, President Trump signed an Executive Order (the “EO”) directing the Department of Justice (DOJ) to complete the rulemaking process related to rescheduling marijuana to Schedule...
The Kids Aren’t Alright: Kids Online Safety Act and Marijuana-Related Speech By Mason Kruse & Hillary Campbell on January 29, 2026 What’s old is new again. The beginning of the year has brought us a sense of renewal, and taking a cue from Congress, we are...
An introduction to the regulatory landscape of THC-containing cannabis in the Netherlands Geert de Nijs 29/01/2026 Netherlands The Netherlands is often seen as a global pioneer in cannabis policy, yet its legal framework for THC-containing cannabis is still one of the...
Schedule III Cannabis: FDA’s New Frontier Schedule III Cannabis: FDA’s New Frontier Article by: Raza Lawrence and Ivy Perez-Bader Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal-law inflection point. Far less attention has been...
Marijuana Rescheduling: Should Employers Update Their Drug Testing Policies and Practices? By Seyfarth Shaw LLP on January 26, 2026 By: Adam R. Young, Jennifer L. Mora, and Frederick T. Smith Seyfarth Synopsis: President Trump’s December 2025 Executive Order signals a...
Jim Ickes Examines Growing Federal Conflict Over State Cannabis Markets (23 January 2026) Despite the rapid expansion of state-legal cannabis markets, the constitutional limits on how states may regulate those markets remain unsettled. One of the most...